Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2008(21): 3433-3442
DOI: 10.1055/s-0028-1083189
DOI: 10.1055/s-0028-1083189
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
Synthetic Studies towards the Development of Psoralen-Acidic Retinoid Conjugates and Hybrids
Further Information
Received
27 May 2008
Publication Date:
16 October 2008 (online)
Publication History
Publication Date:
16 October 2008 (online)
Abstract
The chemical modification of trioxsalen using electrophilic aromatic substitution reactions, followed by either Wittig or Heck reactions or Suzuki coupling, allowed for ready access to C4′ modified trioxsalen derivatives that were successfully used for the preparation of a variety of trioxsalen conjugates with acitretin of either the polyamine or the ester type and trioxsalen-acitretin hybrids.
Key words
electrophilic aromatic substitution - Heck reaction - psoralen-retinoid conjugation - Suzuki coupling - Wittig reaction
- 1
Van der Kerkhof PCM. Neth. J. Med. 1998, 52: 40 ; and references cited therein - 2
Krueger G.Ellis CN. J. Am. Acad. Dermatol. 2005, 53: S94 ; and references cited therein - 3
Leite VC.Santos RF.Chen LC.Guillo LA. J. Photochem. Photobiol., B 2004, 76: 49 ; and references cited therein - 4
Gia O.Magno SM.Gonzalez-Diaz H.Quezada E.Santana L.Uriarte E.Via LD. Bioorg. Med. Chem. 2005, 13: 809 ; and references cited therein - 5
Katz HI.Waalen J.Leach EE. J. Am. Acad. Dermatol. 1999, 41: S7 ; and references cited therein - 6
Pilkington T.Brogden RN. Drugs 1992, 43: 597 ; and references cited therein - 7
Roenigk HH. J. Am. Acad. Dermatol. 1999, 41: S18 ; and references cited therein - 8
Van der Kerkhof PCM. Clin. Exp. Dermatol. 2001, 26: 356 ; and references cited therein - For a review on PACs see for example:
-
9a
Karygiannis G.Papaioannou D. Eur. J. Org. Chem. 2000, 1841 - For some recent examples of medicinally interesting PACs see:
-
9b
Camps P.Formosa X.Muñoz-Torrero D.Petrignet J.Badia A.Clos MV. J. Med. Chem. 2005, 48: 1701 -
9c
Cholody WM.Kosakowska-Cholody T.Hollingshead MG.Hariprakasha HK.Michejda CJ. J. Med. Chem. 2005, 48: 4474 -
9d
Nagarajan M.Morrell A.Antony S.Kohlhagen G.Agama K.Pommier Y.Ragazzon PA.Garbett NC.Chaires JB.Hollingshead M.Cushman M. J. Med. Chem. 2006, 49: 5129 -
9e
Oves D.Fernández S.Verlinden L.Bouillon R.Verstuyf A.Ferrero M.Gotor V. Bioorg. Med. Chem. 2006, 14: 7512 -
9f
Battaglia A.Guerrini A.Baldelli E.Fontana G.Varchi G.Samori C.Bombardelli E. Tetrahedron Lett. 2006, 47: 2667 -
9g
Wu D.Ji S.Wu Y.Ju Y.Zhao Y. Bioorg. Med. Chem. Lett. 2007, 17: 2983 - For the recent development of an α-methylene-γ-butyrolactone-psoralen bisamide heterodimer see:
-
9h
Ropp S.Guy J.Berl V.Bischoff P.Lepoittevin J.-P. Bioorg. Med. Chem. 2004, 12: 3619 - For a recent example of an EC prodrug see:
-
10a
Zakharian TY.Seryshev A.Sitharaman B.Gilbert BE.Knight V.Wilson BE. J. Am. Chem. Soc. 2005, 127: 12508 - See also:
-
10b
Walsh JJ.Coughlan D.Heneghan N.Gaynor C.Bell A. Bioorg. Med. Chem. Lett. 2007, 17: 3599 - 11
Tietze LF.Bell HP.Chandrasekhar S. Angew. Chem. Int. Ed. 2003, 42: 3996 ; and references cited therein - 12
Papaioannou D,Drainas D, andTsambaos D. inventors; WO 2004,018,001. ; Chem. Abstr. 2004, 140, 235912 -
13a
Isaacs ST.Shen C.-KJ.Hearst JE.Rapoport H. Biochemistry 1977, 16: 1058 -
13b
Kim K.Matsuura K.Kimizuka N. Bioorg. Med. Chem. 2007, 15: 4311 - For selected examples of other psoralen derivatives, their synthesis and mode of action, see ref. 4 above and:
-
14a
Oliveira AMAG.Raposo MMM.Oloveira-Campos AMF.Machado AEH.Puapairoj P.Pedro M.Nascimento MSJ.Portela C.Afonso C.Pinto M. Eur. J. Med. Chem. 2006, 41: 367 -
14b
Chimichi S.Boccalini M.Cosimelli B.Viola G.Vedaldi D.Dall’Acqua F. Tetrahedron 2002, 58: 4859 -
14c
Traven VF.Kravtcenko DV.Chibisova TA.Shorshnev SV.Eliason R.Wakefield DH. Heterocycl. Commun. 1996, 2: 345 -
14d
Besson T.Ruiz N.Coudert G.Guillaumet G. Tetrahedron 1995, 51: 3197 -
14e
Bisagni E. J. Photochem. Photobiol., B 1992, 14: 23 ; and references cited therein -
14f
Zubía E.Luis FR.Massanet GM.Collado IG. Tetrahedron 1992, 48: 4239 -
14g
Confalone PN.Confalone DL. Tetrahedron 1981, 37: 1265 - 15
Gaernter R. J. Am. Chem. Soc. 1952, 74: 5319 - 16
Isaacs ST.Rapoport H.Hearst JE. J. Labelled Compd. Radiopharm. 1982, XIX: 345 - 17
Lambertin F.Wende M.Quirin MJ.Taran M.Delmond B. Eur. J. Org. Chem. 1999, 1489 - 18
Travis RB.Sivakumar M.Olatunji Hollist G.Borhan B. Org. Lett. 2003, 5: 1031 - 19
Kaufman KD.Worden LR.Lode ET.Strong MK.Reitz NC. J. Org. Chem. 1970, 35: 157 - 20
Farrar MW.Levine R. J. Am. Chem. Soc. 1950, 72: 4433 -
21a
Ziegler CB.Heck RF. J. Org. Chem. 1978, 43: 2941 -
21b
Mikroyiannidis JA.Yu Y.-J.Lee S.-H.Jin J.-I. J. Polym. Sci., Part A: Polym. Chem. 2006, 44: 4494 - 22
Bryan DB.Hall RF.Holden KG.Huffman WF.Gleason JG. J. Am. Chem. Soc. 1977, 99: 2353 - 23
Trippett S.Walker DM. J. Chem. Soc. 1961, 1266 - 24
Rafecas Jané L,Riera Escalé A,Écija Queralt M,Moyano Baldoire A,Comely A, andCasalprim Castellà I. inventors; WO 2006,067,216. ; Chem. Abstr. 2006, 145, 103949 - 25
Geall AJ.Blagbrough IS. Tetrahedron 2000, 56: 2449